This is the authors' abstract. We don't add key points for this paper.
Two pairs of oppositely charged PEO‐ b ‐poly(amino acid) copolymers with neutral poly(ethylene oxide) block and polypeptide block composed of the hydrophobic l ‐phenylalanine (Phe) amino acid mixed with either negative l ‐glutamic acid (Glu) or positive l ‐lysine (Lys) units are synthesized. N ‐carboxyanhydride (NCA) ring opening polymerization is performed with either PEO 46 ‐NH 2 or PEO 114 ‐NH 2 macroinitiators, leading respectively to PEO 46 ‐ b ‐P(Glu 100 ‐ co ‐Phe 65 ) and PEO 46 ‐ b ‐P(Lys 100 ‐ co ‐Phe 65 ), and PEO 114 ‐ b ‐P(Glu 60 ‐ co ‐Phe 40 ) and PEO 114 ‐ b ‐P(Lys 60 ‐ co ‐Phe 40 ). Polyion complexes (PIC) formed at near charge equilibrium led to vesicle formation (PICsomes), as shown by DLS, zetametry, and TEM. The good stability of PICsomes, even in high salinity media, is interpreted by π π stacking hydrophobic interactions between the Phe residues, playing the role of “physical cross‐linking”. These PICsomes are successfully loaded with small interfering ribonucleic acid (siRNA) directed against firefly luciferase enzyme expression. They also exhibit minimal cell cytotoxicity while superior silencing efficacy is shown by cell bioluminescence assay as compared to free siRNA and a standard lipofectamine‐siRNA complex. As such, self‐assembly of oppositely charged PEO‐ b ‐poly(amino acids) block copolymers enables forming PICsomes of high stability thanks to π π interactions of the Phe co‐monomer in the polypeptide block, with high potential as biocompatible nanocarriers for RNA interference.
No takes yet. Share an insight, caveat, or question.
Aydınlıoğlu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: